Adult
Dosing in obese patients
- Obesity is defined as patients with a BMI over 30kg/m2.
- Obesity is associated with changes in volume of distribution and clearance of some antibiotics.
Advice about the dosing of antibiotics in obese patients is given below. Early discussion with a pharmacist or infection specialist is advised.
Patients with renal and/or hepatic impairment are outside the scope of this document. Discussion with an antimicrobial pharmacist or infection specialist is strongly recommended.
Recommended changes to antibiotic dosing in obese patients
Common measures of weight
For obese patients, alternative measures of weight are sometimes used to modify antibiotic dosing.
Weight type |
Definition |
Used for |
TBW: Total body weight |
Patient’s true weight in kg |
Vancomycin/Teicoplanin Daptomycin |
IBW: Ideal body weight |
50kg (male) or 45kg (female) + 2.3kg for each inch over 5 feet |
Colistimethate sodium |
AdjBW: Adjusted body weight |
IBW + 0.4(TBW – IBW) |
Aminoglycosides |
Therapeutic drug monitoring
- Monitor Vancomycin, Teicoplanin, Gentamicin and Amikacin levels as per standard OUH protocol. See vancomycin, teicoplanin, gentamicin or amikacin monographs.
- Monitoring of other antibiotics can be considered but are send-away tests (to Bristol Antimicrobial Reference Laboratory). Discuss with Infection Team before doing this.